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INTRODUCTION
The Indians of South America have long used a
poison known as curare with which they coated their
arrow points and spear heads.

The composition of curare

was not known until the end of the 19th Century because
its preparation was surrounded by mystery.

The few tribes

who made the poison kept the process of its preparation
carefully guarded for it was a family tradition hundreds
of years old, handed down from one generation to the
next.

Because of this mystery, travelers in South

America were always extremely curious about this poison.
Sir Walter Raleigh in 1569

(1)

was among the first to

give a description of the arrow poison used by the South
American Indians.

Although his description of the death

of individuals struck by these poison arrows is somewhat
different from the symptoms of fatal curare poisoning as
we know them today, the arrow pois on he described was
probably curare.

Edward Bancroft in his book "Natural

History of Guiana" printed in 1769

(2)

tells of the

pre:pa.ration of arrow poison from five different kinds
of bark.

His account is noteworthy because it omits

the highly fanciful and superstitious views found in
earlier writings than contain much material of a "magical" nature.

The first European actually to witness

-2-

the preparation of curare was Alexander von Humbolt
who traveled in South America from 1799 to 1804.

( 3)

He de-

scribed curare as bein g made from the yellow juice of
the creeping plant bejuco de mavacure.

The poison is

contained in the bark and in a part of the sapwood.

The

bark is scraped from the mavacure branches, macerated by
pounding and a cold infusion made.

After several hours

this is filtered and the filtrate boiled to the consistency of molasses.

To give body to the poison and

make it viscid enough to stick to arrows the plant sap
obtained from a tree known as kiraca guero is added to the
concentrated infusion.

As soon as this is added the con-

centrated poison pecomes. black and coagulates to form a
mass having the consistency of tar.

This is crude curare

in the form in which it is received from South America.
Robert Schomburgk
to prepare curare.

(1)

was the first Eur opean

The Indians gathered the necessary

in gredie nts for him but they r efused to prepare the
poison in his presence.

Taking the bark, Schomburgk

succeeded in preparing a poison somewhat less potent than
the curare prepared by the natives.
The first accurate observations on curare were
made by Fontana

(4).

He showed th a t the poison had no

effect on nerves when applied directly to them and when

-3it did not come in contact with any other tissue.

He

also showed that the muscles were inactive before death
but he attributed the cause of death as being due to an
effect of the curare on the blood.

( He noticed that

curarized blood did not clot as readily as non-curarized blood.)

Fontana observed that the po ison was readi-

ly absorbed from wounds and cut surfaces and that very
large oral doses could cause fatal para lysis.
1812

(5),

Brodie in

poisoned animals with woorara an d decided

that the cause of death was due to an effect of the drug
on the brain.

He noted that artificial respiration kept

the animal alive which he believed allowed the animal to
generate heat and thus maintain the integrity of the
nervous system.
It was Claude Bernard

(6),

h owever, wh o

carried out the first physiological experiments with
curare and definitely placed its locus of action at the
peripheral motor nerve terminations, leaving the sensory
nerves still irrit able.

He was not sure whether the

poison a cted on the nerve terminations or upon the myoneural junction but he noted that even the finest nerve
twi gs were capable of conduction after curarization.
Garten

(7)

later showed that the function of motor

nerve trunks is main t ained after twenty-four hours exposure to the purest curarine solution, and that their

-4-

rate of conduction is not diminished.
The chemical and pharmacological aspects of
the curare problem were investigated. by Rudolf Boehm in
1895 and 1897
curare;

( 8) •

He distinguished three kinds of

tubocurare which derives its name from the

bamboo tubes in which it is stored;

calabash curare

stored in calabashes and pot curare which is stored in
small earthenware pots .
Boussingault

(9)

Although Roulin and

in 1828 and later Preyer

(10)

had

attempted to isolate the active compound from crude
curare, the first successful attempt is properly credited
to Boehm .

From each of the three kinds of curare Boehm

isolated an extremely poisonous alkaloid;

tubocurarine

from the tubocurare, curarine from the calabash curare,
and the extremely active protocurarine from pot curare.
Although Boehm correctly supposed the curarines to be
quaternary ammonium bases, he was not able to work out
their chemical formulas.
H. King

(11),

This was later accomplished by

who isolated d-tubocurarine chloride

from tubocurare and worked out its chemical configuration.
The site and mann er of action of curare caused
much controversy among early investigators and as a
result several theories of curarization were propounded.
L.a.picque's theory of heterochronism between nerve and

-5-

muscle
( 13)

(12),

which was later contested by Rushton,

and Langley's

( 14),

intermediate receptive sub-

stance between nerve and muscle are good examples.

At

present, due to recent investi ga tions of McIntyre and
King

(22),

it seems probable that the site of action

of curare is directly on the muscle itself.

This is

also the locus of action of acetylcholine which according to the neurohumoral

theory is liberated at motor

nerve terminations follo wing stimulation.
The theory of the humeral transmission of the
nerve impulse or "Ne urohumoralism" really goes back to

1877 when DuBoise-Reymond

(15)

stated that the trans-

mission of a n erve impulse may be either produced
electrically or by chemical means as by NH 3 or lactic
acid formed at the nerve ending. However, the first
real proof of a chemical mediation of nerve impulses by
the peripheral r e lease of chemical a gents was not until
1921 when Otto Loewi

(16)

ment on frog hearts.

His experiments were duplicated by

Rylandt in 1927

(17)

did his cla ssical experi-

usi~g perfused rabbit hearts

instead of frog hearts and in 1933 Feldberg and Krayer

(18)

extended the field using intact cats and dogs.

Englehart

( 19)

later showed that physiological stimu-

lation of nerves also produced the chemical mediator .

-6He showed that impulses over the short ciliary nerves
produced by exposure to light or to electrical stimulation liberated a substance which imparted to the
aqueous humor the pharmacological properties of acetylcholine.

Dale and Feldberg

(20)

have shown the presence

of acetylcholine in the perfusate from the muscles of
the hind leg of the do g during stimulation of the sciatic nerve.

The perfusate was tested on leech muscle.

Brown

has shown that small doses of acetylcholine

( 21)

injected intra-arterially causes skeletal muscle to contract, that larger doses or t he presence of eserine
cause a contraction followed by paralysis.

Denervation

greatly increases the sensitivity of the muscle for
acetylcholine, very minute amoun t s eliciting a contraction while larger quantities cause a contraction
followed by paralysis.
It is evident that both acetylcholine and
curare exert their effect at the myoneural junction.
Curare could paralyze skeletal muscle by any one or a
combination of 3 different mechanisms.

First, curare

could in some maRn er interfere with the liberation of
acetylcholine at the motor n e rve terminations in skeletal muscle;

secondly, it could inhibit ch oline esterase

which would allow acetylcholine to accumulate at the
nerve terminations and ~hus paralyze the muscle;

third

-7 -

i t could act directly upon the muscle in some manner to
prevent the action of acetylcholine.

Acetylcholine or

an acetylcholine-like substance is liberated from skeletal muscles during stimulation of the motor nerves to
the muscles.

Experiments of McIntyre and King

(23)

have shown that d-tubocurarine chloride in doses sufficient to paralyze voluntary muscles does not interfere
with the liberation of acetylcholine at the motor nerve
terminations nor does it interfere with the liberation of
the "vagus substance" following stimulation of the vagus
nerve of the turtle

(24).

Crude curare markedly inhibits the activity
of choline esterase.

McIntyre and King

(25)

have shown

that pure crystalline d - tubocurarine chloride, the active
alkaloid of tubocurare and recently extracted from
Chondodendron tomentosum has no effect on choline esterase activity in vitro.

It would thus appear that curare

exerts its paralyzing action neither by interfering with
the liberation of acetylcholine nor by any inhibition of
ch oline esterase activity.
Curare evidently exerts its action somewhere
on voluntary muscle itself.

The fact that a direct

stimulus will cause a curarized muscle to contract would
seem to indicate that the actual mechanism of contrac tion is not interfered with, once the process is initi-

-8ated .

Curare greatly diminishes or abolishes the re-

sponse of voluntary muscle to injected acetylcholine.
Eserine or acetylcholine, however, antagonize the
effects of curare and greatly shorten the period of
curarization, in fact, it is almost impossible to give
enough curare to an eserinized animal to produce complete paralysis of the voluntary muscles.
was not until McIntyre and King

( 26)

However, it

discovered that

the rapid intra-arterial injection of d-tubocurarine
chloride in to denerva ted muse le would cause a c on traction
that the mechanism of action of curare was elucidated.
Many other quaternary ammonium bases, as for example,
tetramethyl ammonium chloride, trimethyl sulphonium
iodide and ace\ylcholine, will cause a denervated muscle
to contract when injected intra-arterially with sufficient
rapidity.

(27).

These onium compounds all possess high

reduction potentials .

It seems reasonable to suppose

that t he polarized muscle membrane or some specialized
portion of the muscle fiber in the vicinity of the motor
nerve terminal is peculiarly able to
bases.

t

1

accept" these

The concept of an "acceptance" of special sub-

stances is, of course, not new and was emphasized by
Langley in 1906

(28).

It seems pr obable that this re-

ceptive substance "accepts" both acetylcholine and dtubocurarine chloride and that the very labile acetyl-

-9choline is rapidly destroyed by the choline esterase
present, freeing the muscle for the "acceptance" of
a n other quantity of exciter substance, while on the
other hand, the curarines being more stable remain "in
occupation" of the muscle preventing the "acce ptance "
of acetylcholine.

The similarity of eserine arrl curare

paralysis would appear to support this assumption.
Because the activity of curare is apparently
to cause depolarization of some muscles ubstance, "the
receptive substance,

11

in the region of the motor end

plates of striated muscle, King and Willard

(29)

made

a histological study of the motor en d plates of normal
control muscle, of muscle fatigued by indirect tetanic
stimulation and of striated muscles paralyzed by curare.
In no case did the end plates present any constant change
in appearance or in absolute size.

Only when extremely

large doses of curare were injected directly into the
muse le was there any effect on the end plates.

This

defini t ely shows that pure curarine can :r:ara lyze striated muscle without changing end plate size or affecting
the morphology of the nerve terminals, nor does t h e gold
c h loride method demonstrate acetylcholine at the nerve
t erminals following indirect tetanic stimulation.
It appears highly probable t h en, that d-tubocurari n e ch loride combines in some manner with the

-10-

specialized muscle substan ce or "receptive substance"
at the sole plate to cause an active contraction followed by an inability of the "receptive substa nce" to combine with acetylcholine, res ulting in paralysis .

This

union between "receptive substa nce" and d-tubocurarine
chloride is gradually broken, a process which can be
greatly accelerated by acetylcholine.

Eserine exerts

its effect peripherally by preserving acetylcholine which
would normally be hydrolized by choline esterase.

Thus

acetylchbline and curare are c ompetitors for combination
with the specialized muscle substance, acetylcholine combining an d being quickly hydrolized enabl es the musclefiber a ga in to react to more acetylcholine, while curare
forms a stable combination.

Local changes associated

with t hese chemical combinations can not be demonstrated
histolog ically for it has b e en shown that acetylcholine
and curare cause no significant morphological change at
the myoneural junction.

11

Photomicrograph of Normal Control Motor End
Plate from Albino Rat

X 127 Magni fication
The above photomicrograph was taken of
normal cont.rol gastrocnemius muscle of the albino
i:ia.t, stained by the gold chloride technique.

It

shows a nerve branch which terminates in motor end
plates on several muscle f ibere.

The nerve fibers

and motor end plates are slightly overstained.
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Photomicrograph of Curarized Skeletal Muscle
and Motor End Plates from Albino Rat

X 127 Magnification
,.!['his photomicrograph of curarized ga.stroc
nemius muscle was takeh after the rat had received a
paralyzing dose of d-tubocurarine chloride, stained
by the gold chloride technique.

Note the motor end

plates, although not stained as heavily, have t he
same morphology and size as those of the normal con
trol muscle on the previous page.

Curarization with

a physiological dose of d-tubocurarine chloride has
no morphological effect on the size or shape of motor
end plates of skeletal muscle of the white rat.
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USE OF CURARE IN THE TREATMENT OF TETANUS
Vella

(30)

in 1856 was among the first to

employ curare in the treatment of traumatic tetanus.
He described 3 cases of acute traumatic tetanus which
developed 4, 5 and 3 days respectively following operation for gunshot wounds.

The first two cases died but

t h e t h ird recovered, the spasms ceasing upon the twelfth
day followin g administration of Urari wh ich he employed
locally in t he form of compresses app lied to the wounded
part.

He first used a solution composed of 2 grains of

Urari pe r ounce but soon increased the strength to 20
grains in 3 ounces of water because the weaker solution
. would n ot control the convulsions.

The local application

of urari produced no tissue irritation .

The news of this

so-called "cure" spread rapidly and by 1859 Vella am
Chassaignac

(31)

r eported n ine attempts to treat

tetanus with curare but of t h ese nine atte mp ts there were
seven f ailures a nd in only two cases was the treatment
successful.

The uncertain effect and comp osition of

curare was blamed for these failures.

The curare used

at t h is time was variable a nd uncertain both in its
effect an d composition.

Its ch emical nature was not

uniform and even its source was unc e rta .in.

It was felt

that if 1 t were possible to dis till a deadly poison from

14

II

II

this drug and to extract from it Curarina as its active
alkaloid, a fixed intensity might be attained .

Thus ,

the therapeutic action of curare was unreliable; it
rarely cured, but it c ruld kill promptly .
Largely because of Claude Bernard's physiological experiments with curare, the French doctors had
begun to use curare in the t rea tmen t of tetanus .
Vulpian

(32)

described a case in 1859 which he treated

by the local application of curare .

Symptoms of tetanus

appeared three a nd one half days following trauma tic
fracture of the scapula, and were con trolled by the local
application of a curare solution conta ining ten centigrams of curare in forty cc. of water .
Ma ny such cases appeared in t h e literature
a nd Claude Bernard

(33)

at a meeting of the Academy

of Sciences stated that although curare perhaps had no
direct effect in tetanus, it did prevent muscle spasm
a nd make the patient more comfortable .

He recommended

more study to try to determine which cases would respond a nd should, therefore, be treated with curare .
A few years later, Jousset

(34)

reviewed

severa 1 cases of tetanus treated '111 th curare and stated
it was n ecessary to assay the drug first in order to
establish its potency and then give a dose sufficient
to produce complete rel a xation.

Many of the failures

15

were due to too small a dose.

He recommended inject-

ing a small quantity subcutaneously, leaving the needle
in and repeating the injection (adding to it every

5 min.) until a physiological effect has be~n obtained.
Curare is a rational drug to use and he thought it especially valuable in the trea tment of tetanus.

It does

not modify the course oft etanus but it does give relief
from muscle spasm and the patient is much more comfortable.
Karg

(35)

1883 in a discussion of the treat-

ment of tetanus with curare reviewed 51 cases so treated,
25 of which died, a mortality of 49 per cent.

It was

interesting to note that the incubation period of those
who survived was usually 5 to 7 days or longer.

He con-

cluded that curare did lessen the reflex excitability
and combined with chloral hydrate or morphine lessened
the pain and thus made the patient much more comfortable but there was always the danger of paralyzing the
muscle s of respiration, causing death.

The average

dose of curare at this time seemed to be a bout 1 grain
per hypo every six hours, but the effect obtained was
variable because the solutions were not always freshly
prepared and the a cti vi ty varied with the differences
in the curare and the manner in which the solutions
were prepared.

16

In 1886, M'Ardle

(36)

discussed the treat-

ment of acute traumatic tetanus by curare and stated
that little was known of the pathological affection
present so the knowledge of the treatment oft etanus
was still deficient.

He found curare to be of more

benefit than the accepted treatment of nicotin, aconitin, morphin, calabar bean, chloral hydrate, etc.
A case of tetanus was described developing
10 days after a h e rnia operation.

One half grain of

curare was injected which gave muscle relaxation and
6 hours later another dose was required.

Three-fourths

of a grain was then given every six hours until the
patient was well, a duration of 3 weeks.

The patient

had been bothered with constipation but while receiving
curare the bowels evacuated regularly.

There were no

residual effects from the curare following therapy.
It was thought that mos t of the failures in the JRSt
had been due to the method of giving curare.

Curare

must be made up in fresh solution every few days because
the active principle precipitates with some resinoid
substance.

The c urare solutions should be filtered or

else very troublesome abscesses form at the injection
point .

The chief drawback of curare therapy is the

cessation of respiration which results from overdosage.
At this time there was no known antidote f cr the poison
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and artificial respiration was not too su:: cessful.
•

Largely because of the unsatisfactory results

obtained in the past, interest in the clinical use of
curare in the treatment of tetanus waned during a period
following the turn of the Century, but it was again revived by animal experimentation in the early thirties.
Florey, Harding and Fildes

(37)

used curarine to con-

trol the spasms , in rabbi t s inoculated with tetanus
toxin.

By injections at one half hour intervals, th ,e y

were able to maintain paralysis and so control the
spasms and rigidity.

Using curarine, they found that

in order to control spasms or rigidity, c ample te paralysis of the limbs was necessary .

They found tv.o apparent

dangers from the use of curarine, however, asphixia from
saliva passing back into the throat which could be controlled by atropine, and s toppag~ of the diaphragm from
a slight overdose.

To obviate the latter risk they ad-

vocate the use of a Drinker artificial respirator when
re::iuwed.

They suggest that with these precautions

curarine might be used to control the rigidity and
spasms of tetanus in man.

Curarine is rapidly elimin-

ated so treatment could be quickly stopped if necessary.
West

(38)

showed that certain curares, in

addition to the peripheral paralyzing effect, show a
convulsant action which strongly resembles strychnine.

18

Nb.en used on dogs these curares produced difficulty in
inspiration probably due to bronchial spasm.

Generally

speaking , however, curare l e ft the respiratory mechanism
undamaged until a severe degree of paralysis of the
limb muscles had set in, but the danger of respiratory
embarrassment was one of the reasons for caution in the
use of curarine in the human subject.

In spastic

patients with a pyrami dal lesion, curarine only caused
relaxation by paralysis and the relaxation obtained was
not as satisfactory as that with some samples of crude
curare.
Hartridge and West

(39)

used various samples

of crude curare to control tetany in parathyroidectomized
dog s .

They found considerable variation of s treng,'th in

different samples and found two specimens out of 7 that
possessed the power of removing tetany in the dog without causing paralysis .
West

(40)

showed t hat one of these samples

of curare removed pathological rigidity in man without
causing diminution of voluntary power.
s elective action

11

lissi ve. n

He cal led this

seven teen cases of muscular

ri gidity resulting from disease of the pyramidal and
estra pyramidal motor systems were treated with this
curare.

There was considerable reduction of rigidity

with d oses wh ich caused no detectable weakness or loss

19

of motor power.
West

(41)

employed tubocurarine in the

treatment of a case of spastic paraplegia due to d isseminated sclerosis;

doses of 10 to 20 mg. subcutaneous-

ly caused slight dizziness followed by blurred vision,
slight frontal headache and a sensation of heat and
flushin g .

The strong flexion spasm of the legs became

a little less rigid, but walking was not materially improved.

With 20 mg. these symptoms and signs were in-

creased and the patient could put the right leg to the
ground, but was too dizzy to walk .

With repeated dosage

the patient suffered less from dizziness and was less
spastic.

With 50 mg. well marked symptoms of poisoning

appeared; ptosis of both eyelids, difficult articulation and the patient could not swallow or raise his head.
Tubocurarine could be used clinically to relax spastic
muscles but its relaxation is essentially a paralysis
and is not as good as a good sample of curare.

Curarine

seem ed to be stronger in its action than tubocurarine.
In cases of Parkinsonism or spastic paraplegia there
seemed to be no margin between the dose lessening rigidity and that causing weakness.

Its therapeutic useful-

ness will probably remain very limited.
According to Cole

(42)

t he prognosis of

tetanus, providing there are no other complications

20

present, · can be accurately assessed on the basis of four
consideration s;

the severity of the wound, the presence

or not of local tetanus, the leng th of the incubation
pe riod. and the length of t h e period between the appearance of the first symptoms and the occurren ce of the
first reflex or clonic spasms.

Cases with a super -

ficial wound are usually mild and those with local
tetanus usually recover .

Cases with an incubation period

of 7 days or longer usually recover.

Patie nts with a

period of onset of 3 days or more usually r ecover .
.. eedless to s ay, cases with a short incubation period
or rapid onset of reflex or clonic spasm following
initial symptoms are usually fatal.
Cole

(43)

gave an excellent discussion of

twenty - one cases of tetanus treated at Addenbrook's
Hos pi t al, Cambrid ge.

The cases were divided into four

degrees of severity:
1.

Tho s e ha ving local tetanus only.

2.

In wh ich there was generalized tonic rigidity

involving particularly the masseters, the muscles of
t h e spine, chest and abdomen, to a lesser exten t the
limbs.

This rig idity gradually increases and t h en

slowly pas s es off, the whole process l a sting from 1 to
4 weeks .

Reflex sµ::i.s ms and reflex excitability are

sli gh t or absent .

21

3.

Cases in which the tonic ri g idity passes into

the stage of reflex spasms, occurring at intervals and
brought on by the slightest stimulation.

Such spasms

persist for a few days to a fortnight a n d then cease,
leavi ng the patient again in the state of tonic rigidity, which slowly passes off.
4.

I n which the spasms described in degree 3 come

on rapi d ly, becoming progressive ly more frequent and
prolonged until they are almost continuous, and death,
often preceded by hyperpyrexia of 108 to 110 degrees,
takes place from cardiac or respiratory failure.
Patient s classified in the first two degrees
have usually had antitoxin, or their wound is very
slight.

They have a long incubation period and they

usually recover.

Patie nts of the t h ird degree have an

incubation period of 5 to 14 days and they may recover
while those of the fourth degree h ave an incubation
period of 4 days or less and they do not appear to recover under present treatment.
Treatment of tetanus is directed along three .
lines;

prevention of further absorption of toxin by

the nervous system, prevention of exhaustion by control
of spasms and the giving of sufficient food.
second factor need be considered here.

Only the

Tetanus patients

should be kept as quiet as possible in a darkened room.

22

Many drugs have been advocated for the relief of pain,
the prevention of spasms and for sleep .

Avertin has

proved of great value given rectally in full doses as
for basal anesthia .

In one case it was given for eight

successive nights and in another three tfmes in 24 hours
with no apparent ill effects.

Paraldehyde given rect-

ally in normal saline in doses up to 6 drachms was also
valuable for sle ep .

In some cases paraldehyde was given

by day a nd Avertin by night and the combination appeared
satisfactory.

Inhalation anesthetics were used very

little but gas and oxy gen was preferable to chloroform
a nd e ther.
Curare was used on three cases .

The s p ecimen

used was of the " gourd" variety and had been tested on
parathyroidectomized dogs by West and found to be moderately "lissive. 11

Doses up to 32 mgs. had be en g iven to

a patient with pyramidal ri gidity- and this observation
form e d the basis of dosage.

Curare effectively less-

ened the frequency and severity of the reflex spasms
and reduced t h e tonic ri gidit y of the masseters, back,
abdominal and limb muscl es.

Although some degree of

weakness of the limbs was produced, there never was
complete paralysis.

The use of curare in one case of

intense severity with an incubation period of 48 hours
checked t he spasms, s t opped reflex excitability and

23

made the rigidity very much less .

Before treatment,

swallowing was impossible, even the sight of fluid
would initiate a severe spasm .

Within 10 minutes after

g iving curare, improvement was noted and after 40
minutes, when 45 mg . had been given, the reflex spasms
were almost completely controlled and the patient could
drink fluid without having any spasm .

In spite of the

control of spasm, severe hyperpyrexia (108 degrees)
developed and the patient died eight hours later .
In the second case, curare controlled the re flex spasms and the patient appeared better, but the
pulse rate continued to climb and 24 hours before death
there was a sudden rise of temperature to 104 degrees
and an i ncreased respiratory rate.

It was thought that

although the spasms had been controlled by curare,
t e tanus toxin continued to diffuse into the nervous
system finally affecting the respiratory center and
heat r egulating center.
The third case was that of a 39 year old male
laborer who cut his fin ger on a reed.

Seven days later

his jaw became stiff and he had difficulty in swallowin g .

These symptoms became worse and 2 days later was

admitted to the hospital.

Cn admission he showed trismus,

risus sarc onicus, tonic rigidity of the spine, chest and
abdomen and severe reflex spasms every 10 minutes.

He

•
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was given 200,000 units of antitoxin intravenously and
2000 subcutaneously into the inf ected finger.

Half an

hour later the Whitlow was incised and washed with H202·
Reflex spasms increased in severity and occurred every
minute or so .

During these spasms opisthotonos occurred,

t h e back was rigid and arched between spasms and the
abdomen was board like .

Avertin and paraldehyde were

used during the course of the illness and occasional
small doses of morphine.

From 3 to 6 drachms of paral-

dehyde were given rectally dissolved in normal saline
every day for 10 days .
patient was awake.

Food was given hourly when the

Two days after admission the reflex

spasms were getting more frequent a nd severe and the
patient was showing signs of exhaustion.
with curare was instituted .

Treatment

The patient was given 4

doses subcutaneously of 32 mgs. at 6 hour intervals .
Within 2 hours the patient had less pain and was more
comfortable.

The reflex spasms were less severe, the

tonic rigidity of the arm and abdomen was less and there
was less spasm of the masseters.

Patient complained of

no abnormal sensations and at no' time had difficulty in
breathing .

Three days followin g beginning use of curare,

reflex spasms and rigidity began to get worse a gain .
Three more doses of 32 mg . curare at 6 hour intervals
were therefore given the patient.

Two days later another
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injection of curare had to be given to control reflex
spasm.

Following this there was steady improvement

and spasms gradually became less and less and ceased
12 days after entry into the hospital .

In eleven more

days the tonic rigidity of the abdomen and back had
disappeared and the patient was discharged 32 days
after entry showing no abnormality of the central
nervous system .
These cases show that the sample of curare
used had the power of lessening the reflex spasms and
rigidity of tetanus without causing c anplete paralysis
of the voluntary muscles or embarra ssing respiration .
Such an action may be of value in helping the patient
through the worst period when spasms are most severe,
and so turn the balance in favor of recovery .

Using

curare in this manner it may be possible to save patients
with i ncubation periods between 4 and 7 days who would
otherwise die.

It is unlikely, however, that it will

have any influence on more severe cases of the fourth
de gree in which the toxin has diffused very deeply into
the nervous system.
West

(44)

studied pharmacologically the de-

rivatives of two specimens of tubocurare and examined
four members of Genus strychnos and one Rµbiaceous plant
associated with the curares of British Guiana in an
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attempt to determine the ingredient aDd drug responsible
for the "lissive" action of some samples of crude curare.

s.

Diaboline was the only poison to exert a

action on the dog.

s.

11

lissive"

Diaboline is a quaternary alka-

loid and is reputed to be a constituent of crude curare
but it is not known whether all curares contain this ingredient.

Diaboline was given to a patient suffering

from spastic paraplegia .

A dose of 70 mg . per kilogram

body weight produced vomiting accompanied by pallor,
sweati ng and a rise of pulse rate.

These symptoms were

noted one hour after subcutaneous inJection of the drug.
The ri g idity of the spastic muscles was definitely increased, and they remained so without further symptoms
or si g ns.

The patient , previously able to walk with

difficulty, could not do so during a period of over 36
hours, after which the degree of spasticity which was
present before treatment returned.

At no time was there

any degree of curarization with this dosage of Diaboline.
The factor responsible for the "lissive" action of some
samples of crude curare still remains to be determined.
Curare has recently been used to control convulsio ns in a case of tetanus which developed pneumonia
following use of Avertin rectally

(45).

It was a rather

mild case of tetanus because the incubation period was
one month and the onset of symptoms was slow, about one
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week before entrance to the hospital.

Patient was given

20,000 units of tetanus antitoxin intramuscularly on the
night of admission, and 30,000 units intravenously
followed by 50,000 units intravenously the next day.
Patient had a small local lesion on a finger which was
opened, debrided and dressed with zinc peroxide paste.
He was given Avertin per rectum for the first 48 hours
to control convulsions, but intermittent spasms of the
entire body still occurred, with clonic jerking of the
extremities.

Patient had considerable respiratory de-

pression, obstruction and mucous production which was
relieved some by atropine.
Twenty-four hours after admission the patient
began to develop pneumonia, verified roentgenologically.
Avertin was discontinued and administration of curare was
begun.

Following intravenous curare the patient's jaw

relaxed, opisthotonos disappeared and respiration became
easier.

Patient was able to cough, expectorate, drink

and move about in bed.

The frequency of administration

of curare was determined by the tone of the rectus abdominus muscles.

Although there was much variation in

the 1 ength of the intervals between convulsive attacks,
as well as in their duration and severity, it was found
that usually 50 mg. of curare would keep the patient
comfortable and free from acute spasm for about 3 hours.
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The patient recovered and was discharged on the
eighteenth day after entrJ into the hospital.
It would appear from the previous cases which
have been discussed that the use of curare is definitely indicated in the treatment of tetanus.

This is es-

pecially true for those borderline cases with an incubation period of from 4 to 7 days.

Cases with a short-

er incubation period will probably end fa tally regardless of the treatment and those with a longer incubation
period and a slow onset of symptoms usually recover.

A

major part of the treatment of tetanus is to prevent exhaustion, conserve strength, decrease the pain and let
the patient rest.

Although Avertin, Morphine and

Paraldehyde may allow the patient rest , they exert their
effect through a central depressing action which combined with the toxic effect of tetanus on the central
nervous system, may be sufficient to cause death.
Furthermore, these drugs will not control all of the
reflex spasms as will curare.
Now that curare has been fairly well standardized (Intocostrin*) largely through the efforts of Dr.
A.R. McIntyre working independently with the Research
*Intocostrin is a partially purified extract of crude
curare prepared by E.R. Squibb & Sons.
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Department of Squibb & Co., the dosage can be computed
on the basis of body weight together with a consideration of the clinical symptoms and over-dosage resulting in respiratory paralysis seldom occurs.

USE OF CURARE I N THE TREATME1\JT OF RABIES

The specific effect of curare which was demonstrated in 1857 by Bernard

(6)

quickly led to its use

in the treatment of convulsive conditions, such as
epilepsy, rabi e s, tetanus, chorea, strychnine poisoning
and various tics.

Jousset

(34)

in a discussion of

the therapeutics of curare stated that these conditions
were not specific for the use of curare consequently
many of them were soon dropped .

Especially was t his

true for rabies, due largely to the discovery by Pasteur
in the latter part of the 19th Century of the prevention and treatment of hydrophobia.

Although curare

was employed in the treatment of rabies during the period
from 1857 to 1882, very few cases were reported in the
literature .

Probably the complete lack of recovery in

any case was responsible for the paucity of reports .
An editorial in Lancet, 1878

(46)

that a rabid dog had bitten five persons .

stated

The wounds

had been treated with strong ammonia, the accepted
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treatment.

It was recommended that if any cases of

rabies resulted, they should be treated with curare.
Curare had not been tried in any case of rabies as yet
in Englan~ because of the difficulties which an overdose would present the practitioner in maintaining
respiration.
Penzoldt 1882 ,
phobia with curare.

(47)

treated a case of hydro-

He remarked about the resistance

of this disease to the effects of curare and stated that
he administered within two and one-half hours, doses

•

which, if given at one time would have been lethal.
Even after this dose of curare, "the power of movement
was by no means abolished, for the patient shortly before
death, sprang out of bed in his d elirium."

CLINICAL USE OF CURARE FOR SPASTIC A~m DYSTONIC STATES

Curare has long been used · in certain spastic
and dystonic states because of its relaxing effect on
skeletal muscle.

West

(44)

with curare in 30 patients.

reported favorable effects
He dissolved the drug in

water a nd put it up in sealed ampules to k eep the solutions fresh and free from contamination.

The average

dose ranged from two to twenty mgs. and he described
certain untoward symptoms which he attributed in part
to t h e curine present.

Curine exerts an effect on the
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vascular system to decrease the systolic blood pressure
and t h e pulse rate.
No effect of curare was noted in cases of
epilepsy or in two cases of arterial hypertension with
arteriosclerosis but a favorable result was obtained in
a case of causalgia of the upper extremity.

Curare also

reduced the rigidity of parkinsonism and it was used for
paraplegia inflexion due to syphilitis myelitis, for
vascular hemiplegia (two cases), for multiple sclerosis
with spastic paraplegia , for spasms of the orbicuraris
muscle of the eye a~d for other conditions.

A spastic

hemiplegia present since birth in a thirteen year old
girl was greatly ben efited by a dose of 12 mg. given
intravenously.

The ch ild had spontaneous athetoid move-

ments at times, and the arm would assume unusual postures.

After administration of curare the arm was flaccid

at the side.
Burman

(48)

paralys is with curare.

treated 19 cases of spastic
The dose given depended upon

th e patient's weight and the degree of muscle spasm.

The

average dystonic patient required about 25 mg. intravenously.

Injections were given three times week ly.

Although curare is eliminated intro to three hours ,
there appears to be some action clinically after 12 days
or lon ger.

Repeated administration of curare is not
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harmful and it is not n e cessary to give increasing
doses to ge·t an effect.
Curare h ad an amazing effect in reducing the
muscle spasm and rigidity in cases of Dystonia Musculorum Deformans.

The effect was so great that a bed-

ridden patient may be able to walk.

The effect was

dramatic and gave a better demonstration of the action
of curare than could be obtained in cases of spastic
paralysis.

These patien ts tolerate larger doses of

curare than other spastic patients.

The effect of the

curare is immediate and sometimes maintained several
days.

The curar e may be given every other day but in

some cases weekly injections are sufficient.
Two cases of torticollis resembling spasmodic
(dystonic) torticollis were treated with curare.

One

case seemin g ly of psychic ori gin was "cur ed" by repeated
injections of cura r e.
It is comparatively safe to give properly
assayed curare in therapeutically effective doses.
Drummond

(49)

treated a case of chorea by

the subcutaneous injection of curare.

The 7 year old

girl was treated with potassium bromide and arsenic for
6 weeks t h en brought to t h e hospital because she had

not improved.

Because curare was recommended in hydro-

phobia, it was started 1/20 grain t.i.d. orally and in

'
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a few days increased to 1/10 grain .

This was continued

for two weeks but there was no improvement.

Patient

then was given 6 grains of chloral and 20 grains of
br omide t.i.d. f or 10 days but with no improvement and
the choreic movements became more exaggerated.

Fourteen

weeks after the origin of the attack, more curare was
procured and injected subcutaneously in doses which
increased from 1/40 to 1/4 gra in.

This later dose

effectively relaxed the patient and she became more
nearly steady.
Bennett

(50)

has used Intocostrin in the

treatment of various organic neurologic disorders.
Twelve cases of spastic paralysis were given curare
every other day, 10 mg. per 20 lbs. body weight for a
period of from 3 to 8 months.

On spasticity without

fixed deformity, it produced a definite but transient
relaxing effect.

It reduced incoordination, athetosis

and dysarthria.

While uncer curare therapy most of the

patients progressed favorably.

The treatment was not

deemed dangerous and there were no toxic reactions.
sustained curarization would be of great value in the
treatment of spastic paralysis and extra pyramidal
rigidity states.
Six patients with Parkinsonian syndrome and
Paralysis Agitans were treated with therapeutic doses

A
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of curare.

The rig idity relaxed, tremor and oculogyric

crisis disappeared but the ri gidity am tremor returned
in about one hour when the effects of the drug had worn
off.

There were no advantag es seen for the relaxation

produced by curare ov er that from the belladonna derivatives wh ich can b~ given by mouth.
Four patients with Hunting tons Chorea were
given curare which stopped the incoordinate movements.
The patients obtained much relief and asked f or add itional doses of t he drug .

However, their incoordinate

movements returned within a few hours after injection
of curare.
The effects of curare on athetosis and dy stonia were studied upon adult, athetotic, dystonic
patien ts and upon post-encephalitic dystonic states .
These patien t s relax temporarily for about one hour
followi ng curare injection.

one patient who had suffer -

ed from progressive painful flexor spasm with athetosis and co ntracture of the right hand and fo_ot, for
over ten years due to head trauma with resulting
atrophy of the basal ga ng lia, received complete relief
from the contractural spasms and athetosis for several
hours following curare therapy .

All typ es of anti-

spasmodic drugs and sedatives had been ineffectual in
relaxing the s pa sm or relieving the athetosis .
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Curare was used in only two cases of tetanus• .
Both were moribund patients before curare therapy rut
relaxation of the continuous tetanic co nvulsions was
produced as long as the drug was continued.
Hatoff

(51)

in a discussion of curare

therapy in spastic para lysis stated that further studies
of curare and its substitutes should be made on . spastic
children in the youngest age groups.
may have irreversible contractures.

Older children
Control groups must

be we ll established, and clinical observations should
include actual physical measurements of muscle power
of extensibility of joints in actual degrees.

Electro-

myograrns should be further employed in the evaluation
of this drug before its widespread clinical effectiveness is appraised.
The effects of curare administration to spastic
patients may be divided in to "Central II symptoms, or
symptoms referable to the central nervous system, and
peripheral effects.

Central syrnptons are invariably

manifest when an effective intravenous dose is given .
The symptoms in genera l are quantitatively proportionate to the dose used when the limit of inconstant effect
is rassed.

The patient becomes dizzy, his eyes feel

"fluttery" and it is difficult for him to open his eyes
because of heaviness of the lids .

As the dose is in-
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creased, the symptoms increase.

The patient keeps

the lids ti gh tly closed and finds it increasingly difficult to open them.

Diplopia is not uncommon.

With a

large intravenous dose, certain alarming symptoms may
occur.
Immediately after t h e injection, the face may
assume an expression of stupefaction, the mouth is held
open, saliva may drool from t h e mouth.
face is ashen gray.
pression is fixed.

Color of the

Eyes are half open and their exThe head hangs heavy and limp and

may fall to one side as if the muscles of the neck had
found the burden of the head too great.

The

:p3.

tient

walks as if drunken and cannot take more than a few
steps unsupported.

The limb s feel weak.

These mani-

festatio ns, although alarming, pass away rapidly and
the patient is usually well a gain in 15 minutes.

These

symptoms need never be seen in a dystonic patient if the
dose is kept low and given slowly.
The dose of curare given in the treatment of
dystonic patients does not cause the muscles to become
flaccid, this cou ld be done only with toxic doses.

How-

ever, there does occur an elective release of plastic
~uscular rigidity and spasm, so that the muscles are
made much looser than before.
unaltered.

Normal musculature is

This release may be enough to convert a
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hand wh ich was entirely useless into one in_which some
active coordinated motion can be accomplished.

The

patient feels a grateful loosening of taunt muscles.
This is c onfirmed obj ec ti vely by the greater ease with
which active and passive movements of the muscles are
carried out.

Thus the thumb is better abducted, the

fing ers opened from their fl exed position and the hand
supinated.

Palmar flexion of the wrist is the most

difficult to correct, and a certain amount of rigidity
always remains in the thenar muscles.

Certain groups

of muscles then are more sensitive than others to the
action of curare.
Properly assayed curare is safe if given in
therapeutically effective doses.

It has a -definite

place in the release of s:p3.sms and plastic muscular
rigidity in patients with spastic paralysis.

This re-

lease of spasm and plastic rigidity "is only one phase
of the treatment of spastic paralysis.

It cannot be

expected that the drug should convert a paralyzed
muscle into an active one.

In certain cases the re-

lease of rigidity may allow a muscle not completely
paralyzed to begin functioning actively.

Simple ortho-

pedic operations and continuous training of the muscles
must be used in conjunction with curare.
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MYASTHENIA GRAVIS AND CURARE SENSITIVITY
Bennett et al.

( 52)

have develoi:e d a sensi-

tive test for myasthenia gravis.

The intravenous ad-

ministration of about 1 mg. of standardized curare per
kilogram of body weight produces mild generalized curarization in the normal adult.

In the doubtful case of

myasthenia, 1/20 of this estimated physiologic dose,
injected intravenously over a one minute period, produces a peak reaction within 2 minutes.

Aggravation of

existing myasthenia symptoms, particularly paralysis of
the occulomotor muscles, weakness of the facial muse les
and tongue, and dysarthria and dysphagia, are the positive symptoms of myasthenia.

The test should be termi-

nated within 2 to 3 minutes by the intravenous injection
of 1.5 mg. of prostigmine methylsulfate with 1/100 grain
of atropine sulfate.

All acute effects of curare dis-

appear within one minute together with myasthenic
symptoms if the patient is reactive to prostigmine.
This test is very valuable in ruling out suspected myasthenia in asthenic states such as postencephalitis, psychoneurosis, etc.

In such conditions

the curare test quickly proves the case is not myasthenia
because no symptoms of curarization develop.
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CURARE IN ENDOSCOPY
During the past year or two, curare has been
used in an attempt to relax musculature during endoscopy.

Silverberg and Ansbro

tions of curare to 20 patients .

(53)

gave 21 administra-

They decided that a

satisfactory local anesthesia for endoscopy must be ·obtained prior to the use of curare and that morphine
should also be used prior to endoscopy.

They stated that

the dose of curare varied with each patient and recommended that the first injection be 0.5 mg. per pound
of body weight, less 20 mg., increasing each injection
by 10 mg .

A period of one to one and one-half minutes

should be allowed for each injection.

Curare is to be

used with caution prior to endoscopy in pa.tients with
a marked dimunition in tidal exchange.

Cyanosis with

convulsions occurred in 3 cases of this type while difficulty in breathing maRifested itself in 2 such additional cases.
These authors concluded that curare relaxes
the striated musculature and may be useful in troublesome endoscopies.

On the other hand, since it is diffi-

cult to determine the exact dosage for each patient and
since the effects of the drug are so unpredictable,
they do not feel that curare may be used for endoscopy
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with safety.

To obtain relaxation for endoscopic pro-

cedures they prefer other measures, such as adequate
preoperative medication with barbiturates by mouth and
morphine and atropine by subcutaneous and intravenous
injection, or by the use of intravenous barbiturates.

USE OF CURARE IN CONVULSIVE SHOCK THERAPY

Meduna

(54)

is credited with the introduc-

tion of metrazol convulsive therapy to the treatment of
schizophrenia.

It was soon found, however, to be most

effect,ive for the depressed states, :t:articularly the
reactive depressions.

It was heralded as a specific

for the depressions but was frowned on because of its
orthopedic complications and the fears patients expressed towards it.
The incidence of serious extremity fractures
of the humerus or femur has been estimated to be 1.5 to
2 per cent by Bennett
17.2 per cent.

(55),

and dislocations about

Polatin, Friedman and Harris

(56)

re-

ported that compressive fractures of the spine occurred
in 43 to 51 per cent of cases.

Muscle soreness, es-

pecially backache was even more frequent and in many
cases persisted several weeks after completion of the
treatment.
Electric shock therapy was introduced by
)

41

Cerletti and Bini

(57).

It has been accepted with con-

siderable enthusiasm, and, although most investigators
have been disappointed by their results in the treatment of some phychoses, particularly schizophrenia, it
is an almost specific therapy for the depressions.
Electric shock therapy has almost completely
replaced metrazol convulsive therapy because of certain
advantages in its administration, most obvious of which
is the absence of apprehension or panic in the patie.nt,
which was commonly encountered with metrazol .

In ad-

dition to this, the seizure with the electric shock •
method can be more uniformly produced in a given person
than it can with the drug method .

Also, the seizure

with electric shock is not so severe, and its resulting
complications, therefore, are not so frequent ·.
According to Bennett

(58)

therapy has three main advantages.

electroshock
The patient does

not experience initial aura, fear or pain, no toxins
are introduced into the systemic circulation, and there
is less psychomotor excitement following the treatment.
However, the contention that traumatic incidents are
reduced is definitely disputed.

The same complications

follow electroshock treatment that are produced by
metrazol.

In fact, humeral and scapular fractures may

occur more frequently from electroshock.

Many such
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fractures have been reported.
are frequently overlooked.

Visceral complications

Convulsion from electro-

shock produce petechial hemorrhages in lungs and other
viscera and these undoubtedly result in unrecognized
lesions within muscles, brain, lungs, etc., and probably accou.11.t for the flare up of latent tuberculosis,
thus making therapy unsafe.
Prior to giving a patient electric shock
therapy some neurologists have the family sign a permit,
explaining the complications and the dangers associated
with the treatment.

After this is done, in addition to

the routine physical and neurological examinations and
studies of the blood and urine, some psychiatrists make
an electrocardiographic tracing and a roentgenogram of
the thoracic portion of the sp i ne , anterior and posterior.

Electric shock therapy should not be used in the

presence of coronary disease or advanced heart disease.
The roentgenogram of the spine is to rule out pathologic conditions of t h e bones.

Compression fractures

which may occur almost always involve the thoracic area.
The contra-indications for convulsive therapy,
in addition to advanced heart disease and pathologic
conditions of the bones, are organic disease of the
brain, advanced arteriosclerosis, active tuberculosis,
and thrombophlebitis.
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Since the complications of shock therapy were
most serious in the very age group of patients--those in
middle life or pre-senile depressive _s tates--with which
convulsive shock therapy had proved to be most successful, this state of affairs proved to be a contra-indication to their treatment and led in some instances to
its abandonment.
Bennett

t59)

however, in 1939 developed a

safe method of shock therapy which could be utilize~ on
that group of patients with contra-indications for
straight convulsive therapy.

He combined curare with

metrazol which eliminated all complications.

One mg. of

curare per 2 l bs . body weight was injected intravenously, 2 minutes before the metrazol injection.

Twenty

per cent of a series of patients treated by him were
over 60 years old and showed serious organic disabilities.

There were no resulting complications.
Bennett

(58)

also used curare to control

the convulsive seizures in electroshock therapy .

The

technic employed is identical with curare-metrazol
except a mouth gag is necessary because of the initial
tonic jaw contraction from direct stimulation.

There

are no post -treatment complications, although relaxation of the jaws may occasionally require an airflow
for a few minutes .

By the time consciousness is
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re gained, the curare effect has disappeared.
Rece n tly, Bowman, Soloman and Wortis

(60)

stated that the depressing effect of electric shock
upon the central respiratory system makes it unsafe to
add the depressing effect of curare upon the periphera l
respiratory system.

Bennett

(58)

does not consider

this to be true, in fact, respiratory embarrassment
does not follow the combined electroshock-curare treatment.
With the present method of treatment, there
are very few contra-indications if there is a serious
disabling affective disorder present .
indication.

Age is no contra-

Active systemic infection is the only

absolute contra-indication.

Cardiac problems are dis-

regarded if adequate compensation is present.

Bennett

has successfully treated cases of mitral stenosis complicated by cerebral embolic attacks and fibrillation,
also affective states complicated by pregnancy, coronary
artery disease, extreme hypertension, diabetes, pernicious anemia and thrombo angitis obliterans.
Preliminary curarization increases the scope
of us efulness of convulsive therapy and lessens t.'1-ie
contra-indications and thus improves the therapeutic
resul t s.
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Stewart

(61)

during the past 2 years has

given 845 curare-controlled convulsive shock treatments.

(193 curare-metrazol and 652 curare-electroshock) to
108 patients with no res ulting fractures.

At first he

used curare with a few selected patients, but as its
efficiency was observed , its use was extended to all
convulsive shock cases.

The after-care of convulsive

treated patients is another important consideration,
the care of patien ts following the combined curareelectroshock treatment being easier because there is
less discomfort, restlessness, headache, nausea and
muscular soren ess than following the straight electroshock convulsion alon e.

This is one of the chief ad-

vantag es of curare.
Cummins

(62)

treated 118 patients with

curare-metrazol treatment with only 4 compression
fractures of the vertebrae a nd no other complications
of any kind.

The extent of these fractures, however,

was very slight, and probably resulted from insufficient
curarization of the patient.
Jones and Pleasants

(63)

following Bennett's

suggestion, began using curare in conjunction with
electro-shock convulsions.

Their especial purpose was

to resume convulsive therapy in some patients who had
sh own progress, but who had suffered compression fractures
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of the spine, necessitating suspension of treatment.
Twenty patients were given from 1 to 21 treatments each, a total of 196 in all.

In 18 patients the

purpose of curarization was achieved.

Artificial respi-

ration had to be used two times but no emergency medication was usea.

In the two unsuccessful cases, the

cardiac embarrassment was so marked, after one and two
treatments respectively, that it was deemed unwise to
continue.
If curare is used on pa ti en ts with severe
cardiac disease, curarization must be carried out with
much caution because the period of apnea resulting f:r"om
the convulsion is sometimes prolonged and presumably may
aggravate myocardial changes from sclerotic vessels~
Heldt et al.

(64)

use curare routinely and

in smaller doses than those used by Bennett for metrazol therapy.

Rather than use weight alone as an index

for the dosage of curare, they also take in to considera.tion the general muscular development of the patient.
They have found that 2 cc. of Intocostrin given intravenously is the "working dose" and is the dose that will
give satisfactory curarization of an adult weighing 140
lbs. and of average musculature.

One minute is taken

to inject the drug and the treatment is given 2 minutes
after the injection is completed.

They feel that their
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complications have been almost negligible, although in
100 cases so treated, they had 2 compression fractures
of the thoracic portion of the spine, probably due to
insufficient curarization.
Curare, according to Kui t 'ert

( 65)

has found

its greatest field of usefu.lness as a "shock absorber"
in making safe the use of convulsive shock therapy in
the treatment of certain types of psychoses.

It has

already been used in an estimated 50,000 such treatments
with only one fatality.

This fatality occurred in a

case in which proper precautions were not taken and in
wh ich artificial respiration was not used adequately.
Adequate precautionary measures in the use of curare
require the immediate availability of a solution of
1:1000 epinepherine and a solution of 1:2000 prostigmine
for intravenous use in case of respiratory paralysis .
It is also imperative that the physician be prepared
to administer artificial respiration.
The use of curare, therefore, has opened a
new field in shock therapy by enabling the conservative
physician to extend its use to those patients in the
older a ge groups , many of whom because of various
physica l disabilities have been heretofore denied this
be neficial treatment.

48

SYNTHETIC CURARE-LIKE COMPOUNDS
Since the advent of the clinical use of curare,
it has been difficult to obtain a potent and reliable
curare because of the varying composition of the different samples of crude curare.

It would also be advanta-

geous in t h e control of various spastic and dystonic
states to have a curare or curare-like compound with a
more prolonged therapeutic action.

Because of these

disadvantages with the use of curare, many synthetic
curare-like drugs have been investigated, during recent
years.
Chase and Lehman

(66) investigated 34 syn-

thetic compound s belonging to the curare-like group of
agents to establish more definite data on curare-like
responses.

Compounds possessing 3 methyl groups pre-

sented muscarine like actions characteristic of trimethyl ammonium compounds.

These agents seem to hold

little promise as curare substitutes for therapeutic
application.
Beta -erythroidine hydrochloride and dehydrobeta-erythroidine were effective neuromuscular paralyzants, the latter being about 5 times more potent than
the former.

These substances also produced a central

respiratory depression but the amount required was
several times the i:atal paralytic dose.
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The methyl ester of quinine had about 4 times
the potency of the dimethyl est er.

On the other hand,

quinine ethochloride dihydrate had an activity approaching 2 times that of the monomethyl derivative.

The

duration of action appeared to be somewhat shorter for
the ethyl ester which may be an advantage in its use in
shock therapy.
Quinine ethochloride dihydrate was the only
compound studied which seemed to have possible future
clinical consideration.

Since this compound has not

been used clinically, it is imposs•i ble to make any predictions as to its future use.

However, these compounds

were tested on dogs for their toxicity, gastric absorption and anti-convulsant action.

Based on these com-

parisons, quinine ethochloride, although second in order
of toxicity had the greatest margin of safety.

Its

curariform action was intense but of short duration and
should lend itself for the control of the convulsive
seizures induced with metrazol.
The erythrina alkaloids were also tested by
Rosen et al.

(67)

but Williams

(68)

found their toxic

manifestations precludes their general recommendation
for clinical use.
Quinine methochloride dihydrate has also been
investigated by Harvey

(69)

and has been found to have

50

a marked curariform action but Bennett

(70)

after

clinical trial felt that the quinine derivatives were
not as satisfactory as curare because of a prolonged
apnea and a si gnificant fall in blood pressure .

CURARE IN ANESTHESIA
Ether is capable of producing extreme muscular relaxation, but this relaxation is accompanied by
acidosis, hemoconcentration and g lycogenolysis .
(71).

Cullen

In addition, the abdomen is overactive from ac-

cent uation of the diaphra gmatic movements and the in testines are not contracted and are difficult to confine.

This is followed by a prolong ed post - anesthetic

recovery period, with nausea a~d e mesis, distension
a nd a universal debility which pr edisposes toward
pulmonary complications .
Cyclopropane will produce a mod erately contracted intestine and a quiet abdomen, but alon e, it
is incapable, with voluntary respiration, of supply ing complete muscular relaxation in most persons.

By

means of controlli ng res piration , the relaxation can
be improved.

This tecp.nique however, introduces

poss i bilities of trauma, even in experienced hands.
Alth ough a pparently of little or no practical significance, this technique reverses t he intrathoracic
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cardio-respiratory hynamics.

Complimenting cyclopro-

pane anesthesia with intercostal nerve or abdominal
wall block provides, in most cases, optimum working conditions in the abdomen, but the blocks are not completely dependable and increase the time of c anplete
induction of anesthesia.

Prolonged, high concentra-

tions of eye lo propane seem also to predispose to
arrhythmia and to postanesthetic primary hypotension.
Nitrous oxide, unless accompanied by asphyxia
or complimented with block, is usually unable to produce satisfactory anesthesia for intra-abdominal procedures.

Ethylene is but little better than nitrous

oxide and it is usually necessary to ~dd ether, cyclopropane or nerve block .
Intravenous barbiturates provide excellent
relaxation , quiet breathing and a contracted intestine,
but they predispose toward reflex laryngospasm and prolonged postanesthetic recovery.

For this reason, their

use is particularly hazardous in upper abdominal manipulations.
Intrathecal block will, if properly managed,
res u lt in optimal working conditions for abdomina l procedures.

However, the pg.tient is frequen tly uncomfort-

able because of nausea, the long sustained unaltered
position, and the incompletely suppressed sense of
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traction and pressure .

Many anesthetists compliment

spinal anesthesia with inhalation or intravenous barbiturate anesthesia.

The circulation, also, is often

disturbed and although it can be controlled in . most
instances, its alterat'ions are evidence of serious
interference with the patients compensatory mechanisms.
Occasionally, one must also reckon with neurological
sequellae of intrathecal block in a consideration of
choice of anesthetic techniques.
It becomes apparent that recognized anesthetic agents and techniques fail to fulfill completely
the requirements of good anesthesia for abdominat operations.

These requirements are:

maximum comfort for

the patient, maximum safety for the patient and maximum
convenience for the surgeon.

The use of curare has been

introduced into the field of anesthesia in order to impr ove abdominal muscle relaxation and contract the intestine, and thus approach the ideal state more closely.
Curare is selective in action and affects the
muscles of the head an d neck before progressing to the
muscles of the extremities and abdomen and ultimately
to those of respiration.
last muscle affected.

The diaphragm is said to be the

Curare, in small doses, probably

has no analgesic action.

It pr oduces its effects within

2 minutes when given intravenously,and within 15 minutes
intramuscularly.
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Its action persists for 20 minutes and there is apparen tly little or no cumulative effect on repetition of
the drug within an hour or two

(71).

Overdose of the

drug causes respiratory paralysis, from which recovery
is co mplete if artificial ven tilation of t h e lun gs with
oxy gen is maintained during the paralysis.
Curare (Intocostrin) was first used in general
anesthesia by Griffith and Johnson

(72)

a nd it was

largely due to the influence of Dr. L.H. Wright of E .R.
Squibb and Sons of New York that they first used the
dru g to secure abdominal relaxation.

They used curare

on 25 patients and secured such rapid and complete muscular relaxation and were so well pleased with the results that they published them.

Besides the excellent

muscular relaxati on, there was no serious depressing
effects on respiration , pulse or blood pressure, and
there was no demonstrable post-operative effect of any
kind.

Apparently, the dr ug is very rapidly broken down

and excreted almost as rapidly as it acts, although
there is some evidence from the psychiatric experience
that patients who are given a sec and inject ion on the
same day require a smaller dose to produce the physiological effect.
Intocostrin is given ten to twenty milligrams
per 20 lbs. of body weight.

It is prepared in a solu-
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tion containing 20 mg. of the active curare substance
per cc. so that an average adult dose is 4 to 5 cc.
The patients ranged from 18 to 70 years of age and were
all given cyclopropane anesthesia.
Intocostrin was found to be of value in
hemorrhoidectomy und er general anesthesia, causing excellent relaxation of tbe anal sphincter.

It was also

of value in appendectomies in healthy young adults.
Whe n the sur g eon began to close tbe peritoneum , the
abdominal muscles became tense and 5 minutes after 5 cc.
Intocostrin was administered intravenously, the abdomen
was completely relaxed and tbe surgeon was able to
finish the operation.

.

Intocostrin bad no effect on the muscular

tone of the uterus or cervix but in extremely obese
women where bimanual examination is impossible, it may
relax the abdominal wall sufficiently to allow palpation •
A s hort time after the work of Griff ith and
Johnson

(72)

was published, Cullen

(73)

reported

the use of curare-cyclopropane anesthesia on 131 pa tients
which confirmed entirely the experiences of the former
authors .
Whitacre and Fisher

(74)

used curare in

cesarean sections with satisfactory results.

As much as

55

150 mg . was given intravenously without any apparent
depressing effect on the baby.

The average amount used

in these cases was 100 mg. given either in single or
divided doses.

In all cases the babies cried spontan-

eously or were only slightly depressed.

The respiratory

depression that did occur seemed to depend on the amount
of inhalation anesthesia
used.
,

The use
of curare de'

creased the amount of inhalation anesthetic ordinarily
required for cesarean section, thus decreasing the incidence of severe respiratory depression of the baby.

How-

ever, the depression is still somewhat greater than with
local or spinal anesthesia.
They divided the effect of curare into two
stages:

First , the stage of incomplete relaxation of

the skeletal muscle, and second, the stage of complete
relaxation of skeletal muscle.

In the lower part of

the first stage there is a zone in which muscular spasms
or twitc h ing may occur.

Muscular spasms occur more

frequently with large doses of curare :i;.articularly when
the accompanying general anesthesia is inadequate.

This

muscular hyperactivity may be a serious complication
when it interferes with pulmonary ventilation.

Another

undesirable effect of large doses of curare is the accumulation of thick tenac eous mucous in the mouth and
throat.

Atropine and scopalomine are of value, but they
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do not entirely prevent this hypersecretion of mucous.
Curare was used without general anesthesia in
a few cases.

After the administration of sufficient

drug to cause complete muscular paralysis, loss of consciousness occurred.

When curare is used in this manner,

there may be a post-operative period of respiratory depression .

This causes considerable inconvenienc.e be-

cause artificial respirat~on must be maintained until the
effect of the curare has worn off.
Cullen

(71)

uses curare more freely than

Griffith and obtains relaxation with it, rather than by
increasing the concentration of anesthetic agents.

It

is possible to carry the :r;:atient in light second plane
inhalation anesthesia and with proper doses of curare,
obtain as good relaxation, constriction of the i n testine,
and quiet breathing as with spinal.

When the abdaninal

preparation o~ akin incision is made, the curare is given
intravenously and by the time the peritoneum is opened,
the maximum effect of the initial dose is obtained.
Most adults in good health will tolerate 5 cc. Intocostrin as the initial dose.

If this proves insufficient,

one half to two.-th irds of the initial dose is added after

3 to 5 minutes.

Once complete relaxation is attained,

it can usually be maintained until closure of the
abdomen .

If the procedure lasts longer than 45 minutes,
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it may be necessa.ry to add one half to two-thirds the
initial dose to facilitate closure of the peritoneum.
Respiration may be depressed and then is
characterized by complete intercostal :p3.resis and
shallow, jerky, movements of the diaphragm.
pression lasts only about 5 minutes.

This de-

In 24 of the 800

cases in which curare was used, complete respiratory
IB,ralysis developed but persisted cnly 2 to 5 minutes
and there was a rather quick return to effective minutevolume exchange.

Artificial ventilation by manual com-

pressio n of the rebreathing apparatus was all that was
used for treatment.

It was ne cessary to use prostigmine

in but one case.
Cyclopropane is the anesthetic most frequently used.

With this agent, there is no excessive or pro-

longed respiratory depression with optimal doses of
curare.

The optimal state can be achieved with relative

ease and the patient allowed the benefit of a pleasant
induction, a quick recovery and a minimal post-anesthetic discomfort.

From the authors cl imical exp eri-

ence, curare does not seem to potentiate the cardiac
irregularities produced by cyclopropane and may afford
some protection , although none oould be demonstrated.
Curare is also being used during anesthesia
with nitrous oxide and with ethylene.

It is possible to
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secure good relaxation and a quiet abdomen with et:t.ylene, but it is necessary to use larger doses of curare,
and respiratory depression is more frequent, more marked and prolonged.
It is not necessary to use curare during anesthesia when the barbiturates are introduced intravenously because they alone are capable of producing complete
relaxation, quiet breathing and contraction of the intestine.
If curare is used during ether anesthesia,
the dose must be reduced to one-third that used during
cyclopropane anesthesia, because ether has a marked
curariform action on skeletal muscle.
amply demonstrated by Auer and Meltzer
by Gross and Cullen

(76)

This has been
(75)

and also

who showed that not cnly

ether but avertln and sodium pen tothal as well produce
a block at the neuro-muscular junction, perhaps by interfering with the receptor substance of the muscle.

Curare,

however, is advantageous during ether anesthesia because relaxation can be obtained without deep anesthesia,
but more significantly, it contracts the intestine and
produces a quiet abdomen which is not obtained at the
expense of efficient pulmonary ventilation.
Cullen

(71)

noted no post-anesthetic com-

plications which could be ascribed to curare.

Before
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curare came to be used in combination with cyclopropane,
most of t h e upper abdominal and major lower abdominal
operation s were done with ether anesthesia.

Author has

the impress ion that post-operative pulmonary complications, distension , rete n tion and general debility,
are less frequent since it has been possible to use
gaseous a g ents for this ty pe of surgical procedure.
Curare is a sa.D'.e drug and is valuable in that
it prOV" ides _complete musc ular relaxation and contracts
the i n testin e which materially im:i;roves the working
c ondition of the surg eon without significantly increasing the immediate or ultimate hazard t~ the patient.
Its disadvanta g e is the narrow margin between the effective dose and the dose which pr educ es respiratory
depression .

With p roper control of respiration, this

disadvantage proves to be minimal.
Walter

(77)

states that there are two methods

for t he clinical use of curare.

Griffith with his ex-

tensive experience with cyclopropane uses a relatively
deep cyclopropane anesthesia and one single injection of
100 mg. of Intoc ostrin.

Cullen, on the other hand, finds

such a single .injection insufficient es:i;scially if the
length of operation exceeds half an hour, and uses additional injections of smaller amounts of curare through out the operation .

Walter thinks Cullen's method gives
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a better result.
Walter uses the following technique:

He be-

gins general anesthetic with cyclopropane and as soon
as the first plane of surgical anesthesia is reached,
the patient is wheeled into the operating room.

Simul-

taneously with the preparation of the operative field,
one of the patient's arms is exposed and a needle attached
to a syringe containing 5 cc. of Intocostrin is inserted
into a vein.

As soon as the skin incisio n is made, 3 cc.

of Intocostrin are rapidly injected.

If t h e :pa.tient is

not relaxed by the time the peritoneum is o:i:ened, the
remaining 2 cc. of Intocostrin are added.
20 minutes

After 15 to

it may be necessary to add additional doses

of 1 cc. Intocostrin, depending upon the degree of relaxation needed.
Except for the c range in the respiration,
Intocostrin produces practically no systemic effect, the
blood pressure and pulse remaining unchanged throughout
the operation, however, one must be cautious w 1th the
secondary injections of curare because of its cumulative
acti<n.
Griffith

(78)

considers curare a potentially

dangerous drug and does not use it every day or week
because

i t should be reserved for those cases where its

efficiency is really needed.

Inadequate relaxation is
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not a frequent complication with modern anesthesia
technique and the good anesthetist should not need to
use curare every day or week.

Griffith has found curare

to be required most fre quently in young strong adults
who may be just as resistant to any anesthetic agent as
are some men to the effects of whiskey.

It is not

r e commended as an aid during the excitement of a difficult induction, or for a short procedure such as the
reduction of a dislocation because in these cases an
age nt such as sodium pentothal may do the work better
and with more safety.
Cole

(79)

recently reviewed 100 cases in

wh ich curare was used during anesthesia.

The youngest

patient was 3 y e ars old and weighed 23 lbs.

The oldest,

91 y e ars, and the heaviest patient weighed 222 lbs •
Initial doses ranged from 12 to 100 mg ., avera g e 73.7 mg.
A second dose was given when requested by the sur g eon,
durin g the operation itself or for closing, in 42 cases.
The ti me interva l between doses varied from 10 to 175
minutes.

The average measurable duration of relaxation

produced by a singled ose of curare was 74 minutes.

Al-

though curare is rapidly excreted, the drug appears to
have some cumulative action and second a rrl subsequent
doses were usually 40 mg. smaller than the initial dose.
The relaxation produced by the use of curare
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was graded by the surgeon in each case.

In 92 of tbe

100 cases relaxation was excellent, it was considered
fair in 6 cases and poor in 2 case$.

These last 2 cases

were done near the beginning of the series and probably
had insufficient curare.

With increased experience and

familiarity with the use of the drug, very few failures
to obtain complete relaxation should result.
No effect on respiration was noted in 64 of
the 100 cases.

Mild depression was seen in 24 cases and

severe depression without actual apnea in 8 cases.
was seen in 4 cases.

Apnea

Thus in 12 of the 100 cases, arti-

ficial respiration had to be instituted.
In the entire series, there were no deaths
attributable to curare, and no harmful after-effects.
Lenahan

(80)

fin d s curare useful in several

types of operations in genito-urin ary surgery.

For ex-

ample, in nephrectomi es, a maximum amount of relaxation
is necessary at certain times.

Rather than deepen the

patient to a possibly dangerous level to produce relaxation, one to 3 cc. of curare may be

used to produce

c omplel,e relaxation and the patient is not dangerously
depressed.

Again in ureteral transplants when maximum

relaxation is necessary for short pericxis, curare will
afford a quiet, relaxed, abdomen without dangerous
depression.
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In abdominal prostatectomies, good abdominal
relaxation is necessary for a short time while the hand
is in the abdomen, and again curare provides this relaxation.
Lenahan used curare most with cyclopropane
but it can be used with sodium pentothal.

In giving

curare with sodium pentothal , it must be remembered that
two respiratory depressants are being used simultaneously.

Also, if the same intravenous needle is used for

both a gents, a precipitate is formed which appears to be
precipitated pentothal .

This precipitate is soluble in

an excess of sodium pen tothal solution and possibly in
plasma .
It thus appears that curare has become a valuable adjunct to the anesthetics.

Its great value in

anesthesiology is to produc e adequate muscle relaxation
without the necessity of seriously depressing the pat ient
with the deeper planes of anesthesia.

Its use with cyclo-

pr opane ap:r;:ears to be the anesthetic agent of c hoice because induction is rapid, the patient can be carried in
the second stage of anesthesia or in the first plane of
surgical anesthesia, with good muscle relaxation and
recovery is rapid.

Respiration is not seriously depress-

ed during anesthesia and thus the incidence of post-oper'
ative pneumonia is definitely decreased.
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NEWER USES OF CURARE IN MEDICINE
Ransohoff

(81)

recently described 4 cases

of acute anterior po liomelitis in which curare was successfully used to decrease muscle spasm and rain.

One

case was a girl age 2½ years with nuchal rigidity and
rigidity of the entire back, hamstring spasm and gastrocnemius spasm.

The patient was given 0.9 mg. of curare

p~r kilogram body weight (Intocos t rin).

Within 2 hours

following administration of the drug the child was sitting up and playing .

Definite decrease of the nuchal

ri gidity and rigidity of the back was noticed.
The second case was a girl age 3 with acute
anterior poli omyelitis who displayed nuchal rigidity and
opisthotonos.
t i nua l ly.

The child was irritable and cry ing con-

One half hour afte r administra tion of the same

dose of curare as in the previous case,

the opisthoto-

nous had disappeared and the child was sleeping.

Kernig

sign was no longer positive.
The third case was a boy a ge 10 who was admitted with ptosis of the left eyelid, pg.ralysis of the right
facial muscles and difficulty in swallowing and breathing.

Nuchal rigidity and back spasm were pronounced.

Following administration of curare, his breathing became
easier and he swallowed without difficulty.

The follow-
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ing day his ptosis disappeared and the facial muscles
were much stronger.

On

the second day he was found

sitting up in bed.
The last case was a 13 year old girl with
the diagnosis of acute anterior poliomye litis.

She

had been in the hospital for 5 days during which time
she had been in almost continuous pain which was not
relieved by mild sedation or hot packs.

There was com-

plete paralysis of the left leg, definite abdominal
weakness and weakness of the right quadriceps.

An in-

tramuscular injection of 0.9 mg. per kilogram of curare
was given and within 20 minutes the patient was fast
asleep for the first time since admission.

She slept

for 10 hours at which time she awoke complaining of
pain in the back again.

Following application of hot

packs , the patient dropped off to sleep again.

The

following day there 'was still a great deal of spasm of
her back muscles and rigidity of her back, although her
nuchal rigidity had diminished considerably.

Curare was

given again, the same dose as previously and the patient
has remained free of pain ever since.

Her abdominal

muscles have shown definite improvement in strength but
her back still shows some rigidity.
It is not possible to base an opinion at
present upon just one report but it seems probable that
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curare will find a real field of usefulness in the
treatment of acute anterior p oliomyelitis.
Curare is also finding a use for itself in
the field of orthopedic surgery.

Although there are

no reports as yet in the literature, Dr. Bisgard in a
- personal corpmunication, described its use to produc e
muscle relaxation 1n the reduction of fractures involving the shaft of the femur.

He had used curare in only

two cases in con junction with light genera l anesthesia
and in both cases the fractures were easily reduced.
It seems probab le that curare wi 11 soon become just as
valuable an agent in orthopedics as it is at present in
anesthesiology and psychiatry.

SUMMARY AND CONCLUSIONS

The use of curare appears to be definitely
indicated in the present day treatment of tetanus.

By

preventing exhaustion, conserving strength, decreasing
pain and allowing the patient reet, curare may mean the
difference between life and death, especially in those
borderline cases with an incubation period of from 4 to
7 days.

Cases with a shorter incubation period usually

end fatally regardless of the treatment while those with
a longer incubation period usually recover.

Those cases
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with an incubation period of 4 to 7 days frequently die
even when antitetanus serum is given when central de pressants are given to control convulsions because their
central depressing action combined with the toxic effect
of tetanus toxin on the central nervous system may be
sufficient to cause death.

Furthermore, drugs like

avertin, morphine and paraldehyde are not always sufficient to control all of the reflex spasms as will
curare.
Curare then, because of its relative freedom
from central effect and because of peripheral action to
paralyze skeletal muscle, appears to be the drug of
choice to control convulsions and reflex spasms of
tetanus.
Curare appears to have a beneficial effect
in cases of spastic paralysis.

The only beneficial

effect, of course, is the relaxing action on skeletal
muscle.

Although, the drug is eliminated in 2 to 3

hours, injection of curare 2 to 3 times weekly, effectively reduces muscle spasm.

Curare has a more

amazing effect in reducing muscle spasm and rigidity
in cases of Dystonia Musculorum Deformans than upon any
other spastic condition.

The effect is so great that

a bedridden patient may be able to walk.

The effect is
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dramatic and gives a better demonstration of the action
of curare than can be obtained in cases of spastic paralysis .

These patients tolerate larger doses of curare

than other spastic patients .

The effect of the curare

is immediate and sometimes maintained several days .
The curare may be 8iven every other day but in some cases
weekly inj ec ti ons are s uff ic ien t .
Patients with Park insonian syndrome and Paralysis Agitan s can be co n troll ed by curare but it is
t h e ge n eral consensus of opinion that there are no ad van tag es seen for the relaxation produced by curare over
t hat from the belladonna derivatives wh ich can be given
by mouth .
Curare is used in cases of athetosis and dy stonia which do not r espond to anti-spasmodic drugs and
sedatives .

Curare in these cases will give complete

relief from the contractural spasms and athetosis for
several hours followin g therapy .
The dia gnostic use of curare as a test for
myasthenia g ravis ha s recently been advocated and 1s
valuable in ruling out suspected myasthenia in asthenic
states such as post-encephalitis, psychoneurosis, etc .
In such conditions the curare test qu ickly proves the
case is not myasthenia because no symptoms of curarization develop.
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Curare has also been of some value in en doscopy especially in troublesome cases because of the
relaxation of striated musculature which it induces .
However, curare is probably inferior to other measures
as adequate pre - operative medication with barbiturates
by mouth and morphine and atropine, or by the use of
intravenous barbiturates .
Curare has found a very important place for
itself in convulsive

shock therapy .

It has almost

eliminated the complications of shock therapy and allows
treatment of a large group of pati ents, those in middle
li f e or pre-senile depressive states, with wh ich con vulsive shock therapy had proved to be most successful
but in whom the complicatio ns of s h ock therapy had been
most serious .

The after care of convulsive treated

patients is another important consideration, the care of
patients following the combined curare - electroshock
treatment being easier because th~re is less discomfort,
restlessness, headache, nausea and muscular soreness
than following the straight electroshock convulsion
alone .

The use of curare has opened a new field in

shock therapy by enabling the conservative physician
to extend its use to those patients in t he ol der age
groups, many of whom because of various physical disabilities have been heretofore denied this beneficial
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treatment.
Many clinicians consider the short duration
of action of curare to be the chief disadvanta ge of its
use in producing muscle relaxation.

Because of this,

many curare-like compounds have been investigated
clinically but none have been found to be as effective
or to produce as few side reactions as curare.

Until

the ideal drug can be found, curare will continue to
be used clinically.
Curare has recently found one of its most
important uses in the field of anesthesiology.

Recog-

nized anesthetic a gents and techniques have failed to
fulfill completely the requirements of good anesthesia
for abd ominal operations.

These requirements are:

maximum comfort for the patient, maximum saf e ty for the
patient and maximum convenience for the surgeon.

Curare

has been introduced into the field of anesthesia in
order to improve abdominal muscle relaxation and contract the intestine, thus appDoaching the ideal state
more closely.

Besides the excellent muscular relaxation

t here is no serious depressing effect on respiration,
pulse or blood pressure and no demonstrable post-oper ative effect of any kind .
Intocostrin has also found many other uses in
the field of surgery and orthopedic surgery.

It is of
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value in hemorrhoidectomy because it gives excellent relaxation of the anal sphincter.

It has no effect on the

muscular t9ne of the uterus or cervix and in extremely
obese women where bimanual examination is impossible, it
may relax the abdominal wall sufficiently to allow pal pation .

Cura·re is also used in cesarean sections with

satisfactory r es ults.
effect on the baby.

It has no apparent depressing
It decreases the amount of inha-

lation anesthetic ordinarily required for cesarean section thus decreasing the incidence of severe respiratory
depression of the baby .

However, the depression is still

somewhat greater than with local or spinal anesthesia.
· Curare is or value in young strong adults who
tend to be resistant to most anesthetic agents and pro duces good muscle relaxation even with a small amount of
anesthetic .
Genito-urinary surgery is also aided by the
use of curare.

It produces muscle relaxation in neph-

rectomies and in ureteral transplants.

It is also of

value in abdominal prostatectomies where good abdominal
relaxation is necessary for a short time while the hand
is in the abdomen .
Curare is also a valuable agent in orthopedic
sur gery producing adequate muscle relaxation for the
reduction of difficult fractures, and finally curare has
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recently been used to lessen reflex spasm,

opis-

thotonos and pain during the acute stage of anterior
polio myelitis.
It thus appears that tne use of curare is
definitely established clinically.

The drug which was

at one time a physiological and pharmacological curiosity and knew only to kill, now protects and saves
lives and has earned for itself a worth while position
in the physic ians armamentarium.

-r.~
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